Sponsors are abuzz about site relationship management (SRM). In the first installment of our series, Wyeth describes its efforts to become the sponsor of choice. more...

Why Phase Forward bought Green Mountain Logic, a specialist in Phase I and management of laboratory samples and data. more...

Green Mountain Logic is prospering by helping Phase I clinical sites with labs, scheduling and recruitment. Some predictions about the CRO industry usage of the software. more...

Some customers invest in a clinical trial management system for better visibility into a trial. Others like owning their data for future projects. more...

Software from a Chicago company starts with financial aspects of clinical trials, but ultimately attempts to plan more successful trials. more...

Perceptive Informatics and Tourtellotte Consulting are partners. ClinPage talks with Perceptive’s Jean-Remy Behaeghel about how drug supplies should be managed in complex trials.   more...

Software can help with the underlying goal: to understand how each assumption, however minor or mundane, can affect levels of drug supply. more...

What should be at the center of any system to manage clinical trial data? Who can build it? How much of the functionality can be handled by electronic data capture (EDC)? more...

Without even jumping into EDC, Sanofi-Aventis has built a powerful, economical reporting system that seems to serve both upper management and study teams. more...

Independent research firm says sponsors of clinical trials will increasingly need services and technology from both firms. more...

Advanced Clinical Software (ACS) has joined the Clinical Research Forum IT Roundtable. more...

The firm has new web-based software to plan patient recruitment using real-time data. The system has been rebuilt from the ground up to use EDC, IVR and CTMS data. more...

Aptuit expands its Clinicopia Labeling system, adding it to the Clinical Packaging and Logistics suite and rolling it out to company facilities at all major global locations. more...

more...

Two patients go home in trial run by Parexel. more...

It gets worse . . more...